Cellectar Biosciences Receiveable Turnover 2010-2024 | CLRB
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | MED PRODUCTS | $0.012B | $0.000B |
Cellectar Biosciences, Inc. is developing agents to detect, treat and monitor a broad spectrum of cancers. It uses a novel phospholipid ether platform technology as a targeted delivery and retention vehicle. Cellectar Biosciences Inc., formerly known as Novelos Therapeutics, Inc., is headquartered in Madison, Wisconsin. |